BNP Paribas Financial Markets’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $42.6K | Buy |
|
|||||
|
2025
Q2 | $24.4K | Buy |
|
|||||
|
2025
Q1 | $12.9K | Sell |
|
|||||
|
2024
Q4 | $111K | Sell |
|
|||||
|
2024
Q3 | $268K | Buy |
|
|||||
|
2024
Q2 | $10.2K | Buy |
|
|||||
|
2024
Q1 | $3.67K | Sell |
|
|||||
|
2023
Q4 | $5.11K | Hold |
|
|||||
|
2023
Q3 | $6.22K | Buy |
|
|||||
|
2023
Q2 | $6.01K | Sell |
|
|||||
|
2023
Q1 | $69.6K | Buy |
|
|||||
|
2022
Q4 | $52.4K | Buy |
|
|||||
|
2022
Q3 | $64.9K | Buy |
|
|||||
|
2022
Q2 | $69.2K | Buy |
|
|||||
|
2022
Q1 | $28.4K | Sell |
|
|||||
|
2021
Q4 | $127K | Buy |
|
|||||
|
2021
Q3 | $70.8K | Buy |
|
|||||
|
2021
Q2 | $48.5K | Sell |
|
|||||
|
2021
Q1 | $137K | Buy |
|
|||||
|
2020
Q4 | $78.1K | Buy |
|
|||||
|
2020
Q3 | $56.8K | Buy |
|
|||||
|
2020
Q2 | $8.27K | Sell |
|
|||||
|
2020
Q1 | $69.6K | Buy |
|
|||||
|
2019
Q4 | $71.7K | Buy |
|
|||||
|
2019
Q3 | $42.5K | Sell |
|
|||||
|
2019
Q2 | $37.4K | Sell |
|
|||||
|
2019
Q1 | $61.9K | Buy |
|
|||||
|
2018
Q4 | $12.2K | Buy |
|
|||||
|
2018
Q3 | $13.4K | Sell |
|
|||||
|
2018
Q2 | $15.8K | Sell |
|
|||||
|
2018
Q1 | $74.2K | Sell |
|
|||||
|
2017
Q4 | $84.5K | Buy |
|
|||||
|
2017
Q3 | $37K | Sell |
|
|||||
|
2017
Q2 | $46.5K | Buy |
|
|||||
|
2017
Q1 | $2.57K | Sell |
|
|||||
|
2016
Q4 | $6.51K | Sell |
|
|||||
|
2016
Q3 | $24.3K | Buy |
|
|||||
|
2016
Q2 | $11.3K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $61.4K | Sell |
|
|||||
|
2015
Q3 | $67.3K | Buy |
|
|||||
|
2015
Q2 | $32.4K | Buy |
|
|||||
|
2015
Q1 | $8.93K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $19.8K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $4.07K | Buy |
|